Xbrane Biopharma: Pop up on your boards, ’the third wave’ of biosimilars is rather a tsunami – Vator
Xbrane provides an exceptionally attractive exposure to the rapidly growing biosimilars market without the significant clinical and approval risk that is often present in biotech companies.